Assure Holdings Corp., a provider of intraoperative neuromonitoring and remote neurology services, announced significant corporate developments in a series of press releases and SEC filings. On April 8, 2024, the company's Board of Directors approved an amendment to increase the authorized shares of common stock from 9 million to 250 million, which was subsequently approved by stockholders on May 14, 2024. The Certificate of Amendment was filed with the State of Nevada on May 17, 2024, to effectuate the increase. Additionally, Assure received a decision from the Nasdaq Hearings Panel on May 16, 2024, granting an extension until July 22, 2024, to regain compliance with Nasdaq's listing requirements in light of its upcoming transaction with Danam Health Inc. The company also scheduled a webinar presentation for stockholders and investors on May 17, 2024. These announcements are part of Assure's ongoing efforts to complete a proposed transaction with Danam Health Inc., for which a registration statement containing a prospectus and a proxy statement was filed with the SEC on May 3, 2024. The transaction is subject to stockholder approval and other customary closing conditions.

Assure Holdings Corp., a provider of intraoperative neuromonitoring and remote neurology services, announced significant corporate developments in a series of press releases and SEC filings. On April 8, 2024, the company's Board of Directors approved an amendment to increase the authorized shares of common stock from 9 million to 250 million, which was subsequently approved by stockholders on May 14, 2024. The Certificate of Amendment was filed with the State of Nevada on May 17, 2024, to effectuate the increase. Additionally, Assure received a decision from the Nasdaq Hearings Panel on May 16, 2024, granting an extension until July 22, 2024, to regain compliance with Nasdaq's listing requirements in light of its upcoming transaction with Danam Health Inc. The company also scheduled a webinar presentation for stockholders and investors on May 17, 2024. These announcements are part of Assure's ongoing efforts to complete a proposed transaction with Danam Health Inc., for which a registration statement containing a prospectus and a proxy statement was filed with the SEC on May 3, 2024. The transaction is subject to stockholder approval and other customary closing conditions.